Latest Hypnotics Stories
RICHMOND, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc.
In Spain, 24 percent of women use antidepressants and 31 percent use tranquillizers -- sometimes used to help people sleep, researchers said.
Psychopharmaceutical use has risen over recent years. This is fact, but what is not clear is the reason why. Researchers from four Madrid-based health centers have shown that family conflict is not a significant factor.
RICHMOND, Calif., July 22 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc.
A scary unknown for many children, the prospect of surgery can cause intense preoperative anxiety.
Some people who take the fast-acting sleep-aid zolpidem (Ambien) have been observed walking, eating, talking on the phone and even driving while not fully awake.
Researchers believe they may have discovered a more sophisticated anti-anxiety drug capable of controlling panic attacks without the hefty side effects associated with most currently available treatments.
SEATTLE, June 11 /PRNewswire/ -- Neurim Pharmaceuticals (http://www.neurim.com) presented today the preliminary results of a large-scale Phase III study of Circadin(R) 2mg, prolonged release melatonin in insomnia, demonstrating long term efficacy and safety in elderly patients. The results were reported in the Late Breaking Abstracts session of SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, (APSS) held at Seattle, Washington.
WILMINGTON, Del., June 10 /PRNewswire/ -- Today, the U.S.
A research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia (PI), providing greater insight to the limited understanding of the condition's pathology.